{"id":"NCT00657241","sponsor":"State University of New York at Buffalo","briefTitle":"Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril","officialTitle":"Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-04","primaryCompletion":"2010-04","completion":"2010-04","firstPosted":"2008-04-14","resultsPosted":"2022-05-27","lastUpdate":"2022-05-27"},"enrollment":30,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"Carvedilol CR","otherNames":["Coreg CR"]},{"type":"DRUG","name":"Valsartan","otherNames":["Diovan"]}],"arms":[{"label":"(A) ARB first, beta-blocker second","type":"ACTIVE_COMPARATOR"},{"label":"(B) Beta-blocker first, ARB second","type":"ACTIVE_COMPARATOR"}],"summary":"14-week single blind, double baseline, forced-titration, cross-over comparison of the cardiac benefits of Coreg CR compared to valsartan added to existing ACE inhibition","primaryOutcome":{"measure":"Difference in Resting CTTI Between Carvedilol CR (Beta-blocker) and Valsartan (ARB) in Combination With Lisinopril.","timeFrame":"End of each treatment period (4 weeks on ARB or beta-blocker)","effectByArm":[{"arm":"Carvedilol CR","deltaMin":2447,"sd":547},{"arm":"Valsartan","deltaMin":2500,"sd":561}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.05"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":15},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["23107894"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":30},"commonTop":[]}}